KR20240167444A - 피브릴린 산생 촉진제, 화장료 조성물 또는 피부 외용제, 경구 투여제 및 엘라스틴 섬유 산생 촉진제 - Google Patents

피브릴린 산생 촉진제, 화장료 조성물 또는 피부 외용제, 경구 투여제 및 엘라스틴 섬유 산생 촉진제 Download PDF

Info

Publication number
KR20240167444A
KR20240167444A KR1020247035488A KR20247035488A KR20240167444A KR 20240167444 A KR20240167444 A KR 20240167444A KR 1020247035488 A KR1020247035488 A KR 1020247035488A KR 20247035488 A KR20247035488 A KR 20247035488A KR 20240167444 A KR20240167444 A KR 20240167444A
Authority
KR
South Korea
Prior art keywords
skin
production
fibrillin
precursor
accelerator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247035488A
Other languages
English (en)
Korean (ko)
Inventor
가즈야 이시게
Original Assignee
야마사 쇼유 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마사 쇼유 가부시키가이샤 filed Critical 야마사 쇼유 가부시키가이샤
Publication of KR20240167444A publication Critical patent/KR20240167444A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020247035488A 2022-03-30 2023-03-30 피브릴린 산생 촉진제, 화장료 조성물 또는 피부 외용제, 경구 투여제 및 엘라스틴 섬유 산생 촉진제 Pending KR20240167444A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2022-056621 2022-03-30
JP2022056621 2022-03-30
PCT/JP2023/013439 WO2023191016A1 (ja) 2022-03-30 2023-03-30 フィブリリン産生促進剤、化粧料組成物又は皮膚外用剤、経口投与剤、及びエラスチン線維産生促進剤

Publications (1)

Publication Number Publication Date
KR20240167444A true KR20240167444A (ko) 2024-11-26

Family

ID=88202311

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247035488A Pending KR20240167444A (ko) 2022-03-30 2023-03-30 피브릴린 산생 촉진제, 화장료 조성물 또는 피부 외용제, 경구 투여제 및 엘라스틴 섬유 산생 촉진제

Country Status (4)

Country Link
EP (1) EP4501333A4 (https=)
JP (1) JPWO2023191016A1 (https=)
KR (1) KR20240167444A (https=)
WO (1) WO2023191016A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050034902A (ko) 2003-10-10 2005-04-15 미래산업 주식회사 부품 흡착 감지 시스템 및 그 방법
JP2014088329A (ja) 2012-10-29 2014-05-15 Picaso Cosmetic Laboratory Ltd 美容用組成物
KR20190021988A (ko) 2017-08-24 2019-03-06 (의료)길의료재단 지질 대사체의 발현 변화를 이용한 대장암의 발암 과정 예측 및 대장암의 예방 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06172186A (ja) * 1992-12-04 1994-06-21 Toyama Chem Co Ltd アシル−補酵素ａ：コレステロールアシル転移酵素阻害 剤
KR100977475B1 (ko) * 2004-05-21 2010-08-23 주식회사 머젠스 히아루론산, 글리코사미노글리칸 및/또는 콜라겐의생합성을 촉진하는 우리딘 및 우리딘 유도체
KR101073854B1 (ko) * 2010-07-28 2011-10-14 주식회사 머젠스 히아루론산, 글리코사미노글리칸 및/또는 콜라겐의 생합성을 촉진하는 우리딘 및 우리딘 유도체
EP3099801B1 (en) * 2014-01-31 2020-03-18 Factor Bioscience Inc. Synthetic rna for use in the treatment of dystrophic epidermolysis bullosa
SG11202000615VA (en) * 2017-07-24 2020-02-27 Otsuka Pharma Co Ltd Topical composition
JP7541321B2 (ja) * 2020-02-14 2024-08-28 丸善製薬株式会社 ヒアルロン酸合成酵素３（ＨＡＳ３）ｍＲＮＡ発現促進剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050034902A (ko) 2003-10-10 2005-04-15 미래산업 주식회사 부품 흡착 감지 시스템 및 그 방법
JP2014088329A (ja) 2012-10-29 2014-05-15 Picaso Cosmetic Laboratory Ltd 美容用組成物
KR20190021988A (ko) 2017-08-24 2019-03-06 (의료)길의료재단 지질 대사체의 발현 변화를 이용한 대장암의 발암 과정 예측 및 대장암의 예방 방법

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
나카무라 도모유키, 「생체의 신축성을 만들어 내는 구조」, 일본 향장품 학회지 Vol.43, No.1, pp.14-17(2019)
코바야시 와호 외 5명, 「시각적 탄력에 관한 검토」, 일본 화장품 기술자회지 2011년 45권 3호 p.212-217

Also Published As

Publication number Publication date
EP4501333A4 (en) 2026-04-01
EP4501333A1 (en) 2025-02-05
JPWO2023191016A1 (https=) 2023-10-05
WO2023191016A1 (ja) 2023-10-05

Similar Documents

Publication Publication Date Title
JP5635226B2 (ja) 毛乳頭細胞増殖促進剤
JP6058532B2 (ja) エンドセリン−１産生抑制用組成物、及び細胞増殖促進用組成物
JP7300988B2 (ja) 外用組成物
EP1547577B1 (en) Antiaging composition
JP5241054B2 (ja) コラーゲン合成促進用組成物
EP2238971B1 (en) Composition for external application
JP7812228B2 (ja) コラーゲン産生促進剤、シワ改善剤、皮膚外用剤および美容飲食品
JP2017031108A (ja) ウロリチン類を含有する、抗しわ剤、コラーゲン産生促進剤、ｍｍｐ−１産生抑制剤、及びエラスターゼ活性阻害剤
KR20240167444A (ko) 피브릴린 산생 촉진제, 화장료 조성물 또는 피부 외용제, 경구 투여제 및 엘라스틴 섬유 산생 촉진제
JP2005263794A (ja) コラーゲン合成促進用組成物
EP4501405A1 (en) Collagen production promoter, cosmetic composition or external preparation for skin, and preparation for oral administration
JP2017014154A (ja) ウロリチン類を含有するヒアルロン酸産生促進剤
WO2013054760A1 (ja) 化粧料
EP4414001A1 (en) Skin care composition and use thereof, and skin care composition source material
US11547652B2 (en) Combination products and cosmetic compositions for controlling skin disorders and skin aging that affect keratinocytes and/or fibroblasts and the dermis
JP7736256B2 (ja) 環状ホスファチジン酸含有組成物及び美容方法
JP5520703B2 (ja) コラーゲン合成促進用組成物
JP2013203729A (ja) コラーゲン産生促進剤
JP7203519B2 (ja) クローディン発現促進剤およびタイトジャンクション形成促進剤
KR102083405B1 (ko) 스티풀레아노사이드 r1을 유효성분으로 함유하는 피부 노화 방지 및 주름 개선용 조성물
WO2010137335A1 (ja) α－リポ酸ナノ粒子を含有する、ターンオーバー促進用組成物
HK40021191A (zh) 外用组合物
JP2013203731A (ja) ヒアルロン酸産生促進剤
JP2013170150A (ja) ヒアルロン酸オリゴ糖を有効成分とする分子シャペロン発現誘導剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000